Christian Kersten

Summary

Country: Norway

Publications

  1. pmc Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab
    Janne B Kjersem
    Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
    BMC Cancer 12:534. 2012
  2. pmc Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study
    Marte G Cameron
    Center for Cancer Treatment, Sørlandet Hospital Trust, Service Box 416, 4604 Kristiansand, Norway
    BMC Res Notes 4:252. 2011
  3. pmc BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1
    Christian Kersten
    Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
    BMC Immunol 6:9. 2005
  4. ncbi request reprint BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3
    Christian Kersten
    Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
    Exp Hematol 34:72-81. 2006
  5. ncbi request reprint Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells
    Einar A Sivertsen
    Department of Immunology, Institute of Cancer Research, Rikshospitalet Radiumhospitalet Medical Centre, Oslo, Norway
    Eur J Immunol 37:2937-48. 2007
  6. pmc Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
    Marit Synnestvedt
    Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
    BMC Cancer 12:616. 2012
  7. ncbi request reprint Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2
    Christian Kersten
    Department of Immunology, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
    Cancer Immunol Immunother 53:1119-26. 2004
  8. doi request reprint Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial
    Paal Fr Brunsvig
    Department of Clinical Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
    Clin Cancer Res 17:6847-57. 2011

Collaborators

Detail Information

Publications8

  1. pmc Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab
    Janne B Kjersem
    Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
    BMC Cancer 12:534. 2012
    ....
  2. pmc Patient reported outcomes of symptoms and quality of life among cancer patients treated with palliative pelvic radiation: a pilot study
    Marte G Cameron
    Center for Cancer Treatment, Sørlandet Hospital Trust, Service Box 416, 4604 Kristiansand, Norway
    BMC Res Notes 4:252. 2011
    ..abstract:..
  3. pmc BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1
    Christian Kersten
    Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
    BMC Immunol 6:9. 2005
    ..A potential role of BMP-6 in the immune system has been implied by various studies of malignant and rheumatoid diseases. In the present study, we explored the role of BMP-6 in normal human peripheral blood B cells...
  4. ncbi request reprint BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3
    Christian Kersten
    Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo, Norway
    Exp Hematol 34:72-81. 2006
    ..Bone morphogenetic proteins (BMPs) are multifunctional cytokines previously found to regulate hematopoietic stem cells. In the present study, we have explored the role of BMP-6 in human B progenitor cells...
  5. ncbi request reprint Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells
    Einar A Sivertsen
    Department of Immunology, Institute of Cancer Research, Rikshospitalet Radiumhospitalet Medical Centre, Oslo, Norway
    Eur J Immunol 37:2937-48. 2007
    ..However, we did not observe significant changes in Id protein expression in CD4(+) T cells. Altogether, the data indicate a role for BMP-6 in human T lineage cells...
  6. pmc Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
    Marit Synnestvedt
    Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
    BMC Cancer 12:616. 2012
    ..The present study explores the use of DTCs to identify adjuvant insufficiently treated patients to be offered secondary adjuvant treatment intervention, and as a surrogate marker for therapy response...
  7. ncbi request reprint Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2
    Christian Kersten
    Department of Immunology, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
    Cancer Immunol Immunother 53:1119-26. 2004
    ..We conclude that the SEREX approach with a B-cell cDNA source is applicable in NHL. Furthermore, we identified genes with possible involvement in the pathogenesis of BL using this technique...
  8. doi request reprint Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial
    Paal Fr Brunsvig
    Department of Clinical Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
    Clin Cancer Res 17:6847-57. 2011
    ....